
Amanda C. Walke
Examiner (ID: 15144, Phone: (571)272-1337 , Office: P/1722 )
| Most Active Art Unit | 1722 |
| Art Unit(s) | 1722, 1737, 1752, 1795 |
| Total Applications | 2746 |
| Issued Applications | 2313 |
| Pending Applications | 137 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18895622
[patent_doc_number] => 20240011107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => LIVE CELL ASSAY FOR PROTEASE INHIBITION
[patent_app_type] => utility
[patent_app_number] => 18/035021
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035021 | LIVE CELL ASSAY FOR PROTEASE INHIBITION | Nov 11, 2021 | Pending |
Array
(
[id] => 17548436
[patent_doc_number] => 20220119777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => CHEMILUMINESCENCE PHOTODYNAMIC VIRUS INACTIVATION OF RED BLOOD CELLS
[patent_app_type] => utility
[patent_app_number] => 17/506649
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506649
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506649 | CHEMILUMINESCENCE PHOTODYNAMIC VIRUS INACTIVATION OF RED BLOOD CELLS | Oct 19, 2021 | Abandoned |
Array
(
[id] => 17548502
[patent_doc_number] => 20220119843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/502979
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502979
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502979 | RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME | Oct 14, 2021 | Pending |
Array
(
[id] => 17482626
[patent_doc_number] => 20220090130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA)
[patent_app_type] => utility
[patent_app_number] => 17/409774
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409774 | MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA) | Aug 22, 2021 | Pending |
Array
(
[id] => 17212957
[patent_doc_number] => 20210346293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Lipid Vesicle for Oral Drug Delivery
[patent_app_type] => utility
[patent_app_number] => 17/384573
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384573 | Lipid Vesicle for Oral Drug Delivery | Jul 22, 2021 | Abandoned |
Array
(
[id] => 17200477
[patent_doc_number] => 20210340572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => HIGH-CONTENT IMAGING OF MICROFLUIDIC DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/375324
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375324 | HIGH-CONTENT IMAGING OF MICROFLUIDIC DEVICES | Jul 13, 2021 | Pending |
Array
(
[id] => 17357068
[patent_doc_number] => 20220017864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS OF IDENTIFYING IMMUNOMODULATORY GENES
[patent_app_type] => utility
[patent_app_number] => 17/333903
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333903
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333903 | METHODS OF IDENTIFYING IMMUNOMODULATORY GENES | May 27, 2021 | Abandoned |
Array
(
[id] => 18483640
[patent_doc_number] => 20230210941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/998330
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998330 | COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE | May 10, 2021 | Pending |
Array
(
[id] => 20478850
[patent_doc_number] => 12527305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Porcine reproductive and respiratory syndrome virus resistant animals
[patent_app_type] => utility
[patent_app_number] => 17/242963
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8174
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242963 | Porcine reproductive and respiratory syndrome virus resistant animals | Apr 27, 2021 | Issued |
Array
(
[id] => 20479359
[patent_doc_number] => 12527822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction
[patent_app_type] => utility
[patent_app_number] => 17/234603
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 38
[patent_no_of_words] => 6060
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234603
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234603 | Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction | Apr 18, 2021 | Issued |
Array
(
[id] => 18420192
[patent_doc_number] => 20230174653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => B7-H3 CHIMERIC ANTIGEN RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/917198
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917198 | B7-H3 CHIMERIC ANTIGEN RECEPTORS | Apr 5, 2021 | Pending |
Array
(
[id] => 19778730
[patent_doc_number] => 12227754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Adenoviral expression vector and methods and cell lines for production
[patent_app_type] => utility
[patent_app_number] => 17/223785
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17782
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223785 | Adenoviral expression vector and methods and cell lines for production | Apr 5, 2021 | Issued |
Array
(
[id] => 16977884
[patent_doc_number] => 20210222121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/221683
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221683
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221683 | COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION | Apr 1, 2021 | Abandoned |
Array
(
[id] => 16975778
[patent_doc_number] => 20210220015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/221682
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221682 | COMPOSITIONS AND METHODS FOR ENHANCING SPERM FUNCTION | Apr 1, 2021 | Abandoned |
Array
(
[id] => 17065804
[patent_doc_number] => 20210268019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => TARGETED EXPRESSION OF MICROBIAL CHOLESTEROL CATALYSIS GENES REDUCES EXCESS LIPID
[patent_app_type] => utility
[patent_app_number] => 17/187509
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187509 | TARGETED EXPRESSION OF MICROBIAL CHOLESTEROL CATALYSIS GENES REDUCES EXCESS LIPID | Feb 25, 2021 | Pending |
Array
(
[id] => 17197732
[patent_doc_number] => 20210337826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/179100
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179100
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/179100 | MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS | Feb 17, 2021 | Abandoned |
Array
(
[id] => 19883046
[patent_doc_number] => 12268728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1
[patent_app_type] => utility
[patent_app_number] => 17/287443
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6289
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287443 | Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1 | Feb 1, 2021 | Issued |
Array
(
[id] => 17981310
[patent_doc_number] => 20220347346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => MESENCHYMAL STEM CELL SHEET AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/430086
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430086 | MESENCHYMAL STEM CELL SHEET AND USE THEREOF | Jan 21, 2021 | Pending |
Array
(
[id] => 16964225
[patent_doc_number] => 20210215724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHOD OF TREATING PLASMA FOR USE
[patent_app_type] => utility
[patent_app_number] => 17/143699
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17143699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/143699 | METHOD OF TREATING PLASMA FOR USE | Jan 6, 2021 | Abandoned |
Array
(
[id] => 18451927
[patent_doc_number] => 20230193206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Method for Producing Serum for Culturing Mammalian Cells
[patent_app_type] => utility
[patent_app_number] => 17/789314
[patent_app_country] => US
[patent_app_date] => 2020-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789314 | Method for Producing Serum for Culturing Mammalian Cells | Dec 24, 2020 | Pending |